- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 14.08. | BioNexus Gene Lab Corp - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 28.07. | BioNexus Gene Lab Corp - 8-K, Current Report | 1 | SEC Filings | ||
| BIONEXUS GENE LAB Aktie jetzt für 0€ handeln | |||||
| 28.07. | BioNexus Gene Lab Corp.: BioNexus Advances VitaGuard Southeast Asia Rollout Following China Working Visit | 1 | GlobeNewswire (USA) | ||
| 03.07. | Eastwood Bio-Medical Canada Inc: Eastwood signs research agreement with BioNexus | 1 | Stockwatch | ||
| 05.06. | BioNexus Gene Lab Corp - 8-K, Current Report | 2 | SEC Filings | ||
| 29.05. | BioNexus Gene Lab Corp. Calls for Malaysia-China Biotechnology Cooperation to Move Beyond Trade into Co-Development | 1 | GlobeNewswire (USA) | ||
| 15.05. | BioNexus Gene Lab Corp - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 14.04. | BioNexus Gene Lab Corp - 10-K, Annual Report | - | SEC Filings | ||
| 31.03. | BioNexus Gene Lab Corp - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | - | SEC Filings | ||
| 11.03. | BioNexus Gene Lab Corp. Announces Appointment of Dr. Muthu Meyyappan as Chief Commercial Officer of Fidelion Diagnostics to Lead Global Commercialization of the VitaGuard MRD Platform | 900 | GlobeNewswire (Europe) | KUALA LUMPUR, Malaysia, March 11, 2026 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ: BGLC) today announced that, in connection with its Fidelion Diagnostics Pte. Ltd ("Fidelion") transaction... ► Artikel lesen | |
| 23.02. | BioNexus Gene Lab Corp. Completes Chemrex Governance Restructuring; Appoints Matthew Barsing as Chairman | 301 | GlobeNewswire (Europe) | Enhanced board oversight aligns subsidiary with disciplined capital allocation and strategic evaluation framework KUALA LUMPUR, Malaysia, Feb. 23, 2026 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp.... ► Artikel lesen | |
| 02.12.25 | BioNexus Gene Lab Corp. (Nasdaq: BGLC) Secures $500 Million Equity Facility From ARC Group International to Support Expansion of Precision Diagnostics, CDMO Operations, and Therapeutic Commercialization | 251 | GlobeNewswire (Europe) | SHERIDAN, Wyo., Dec. 02, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. ("BGLC" or the "Company"), an emerging provider of precision oncology diagnostics with expanding operations across Southeast... ► Artikel lesen | |
| 20.10.25 | BioNexus Gene Lab Corp.: BioNexus Gene Lab Corp Signs Strategic Partnership Term Sheet with BirchBioMed Inc. | 610 | GlobeNewswire (Europe) | KUALA LUMPUR, Malaysia, Oct. 20, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp (Nasdaq: BGLC, "BGLC", or the "Company"), today announced that it has entered into a non-binding Strategic Partnership... ► Artikel lesen |
13 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| DRAEGERWERK | 113,00 | +0,53 % | Drägerwerk-Aktie // Dicker Freudensprung | Bei Drägerwerk läuft das Geschäft weiterhin sehr gut. Dies belegen überzeugende Zahlen für das erste Halbjahr. So erhöhte sich der Umsatz um 6,2 Prozent auf rund 1,6 Milliarden Euro. Bereinigt wäre... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 10,400 | +0,29 % | Alignment Healthcare USA, LLC: Alignment Health's Fifth Annual Survey Finds Seniors Falling Further Behind: Aging in Place Challenges Continue to Rise as Support Gaps Widen | ||
| FRESENIUS | 45,390 | -0,69 % | JPMORGAN stuft Fresenius SE auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Fresenius auf "Overweight" belassen. Die Experten Anchal Verma und David Adlington bleiben für die europäischen Medizintechnikunternehmen... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 38,870 | -0,31 % | JPMORGAN stuft Siemens Healthineers auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Siemens Healthineers auf "Overweight" belassen. Die Experten Anchal Verma und David Adlington bleiben für die europäischen Medizintechnikunternehmen... ► Artikel lesen | |
| GENEDX | 94,64 | 0,00 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| FRESENIUS MEDICAL CARE | 39,780 | +0,56 % | JPMORGAN stuft FMC FRESENIUS MEDICAL CARE AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat FMC auf "Underweight" belassen. Die Experten Anchal Verma und David Adlington bleiben für die europäischen Medizintechnikunternehmen wegen des... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 19,300 | 0,00 % | Oppenheimer reiterates Procept BioRobotics stock rating | ||
| BRIGHTSPRING HEALTH SERVICES | 58,84 | 0,00 % | Here's Why You Should Add BrightSpring Stock to Your Portfolio Now | ||
| HEARTFLOW | 48,280 | -0,10 % | Heartflow, Inc.: Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half | FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty, supporting... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 13,065 | +0,04 % | LifeStance Health auf Morgan Stanley Konferenz: Wachstum und Margen im Fokus | ||
| AVEANNA HEALTHCARE | 14,325 | 0,00 % | Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| BETA BIONICS | 19,260 | +0,16 % | Beta Bionics, Inc.: Beta Bionics Announces FDA Clearance of Mint, the Company's Transformative Patch Pump, and Unveils 3D Intelligence as its Next-Generation Insulin Dosing Algorithm | Mint features a new and innovative patch pump architecture Full Mint U.S. commercialization expected to begin in Q1 2027 Manufacturing capacity expected to produce at least 1.5 million disposable... ► Artikel lesen | |
| TENON MEDICAL | 5,030 | -0,59 % | Tenon Medical Announces Closing of Warrant Inducement Offering for Aggregate Gross Proceeds of Approximately $2,872,338 | LOS GATOS, CA / ACCESS Newswire / September 14, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 30,000 | -0,92 % | 589 Millionen Menschen mit Diabetes: Warum die globale Diabetes-Welle zum Technologiethema für die Augen wird - und wo Rise Nano Optics ins Spiel kommt | ||
| BILLIONTOONE | 104,19 | -0,08 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen |
BIONEXUS GENE LAB CORP gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 1,470 Euro und damit -1,34 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BIONEXUS GENE LAB CORP finden Sie auf Wallstreet Online.